# Novomore Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/novomore-biotechnology

- Industry: Biotechnology
- Headquarters: Changsha, China
- Website: www.novomorebio.com/
- Latest round: Angel (Jul 3, 2024)
- Investors on record: 2

## About

Founded in 2022 and headquartered in Changsha, China, Novomore Biotechnology focuses on high-value products derived from plant synthetic biology. In September, 2025, it closed a series A funding. 
Novomore Biotechnology is developing high-activity biological compounds for the biopharmaceutical industry. The company emphasizes sustainable practices in producing innovative therapies and treatments leveraging the unique properties of plant-derived materials. 
Revenue is generated through direct B2B sales of biotechnological products to pharmaceutical firms and research organizations. 
The company plans to launch new biotechnological products aimed at addressing healthcare needs while targeting expansion into international markets by leveraging its recent funding to support these initiatives.

## Funding rounds

- Angel, Jul 3, 2024 — Sunz Fund, Lushan Chuangxing Venture Capital

## Investors

- Sunz Fund (https://capitalatlas.ai/funds/sunz-fund) — Angel
- Lushan Chuangxing Venture Capital — Angel